Webinar February 2019: Practical Experiences with Lipid Injectable Emulsions

Feb 04, 2019 02:00pm -
Feb 04, 2019 03:30pm
(GMT-5)

Event Description

Practical Experiences with Lipid Injectable Emulsions
February 4, 2019

 


 

Practical Experiences with Lipid Injectable Emulsions
Date: February 4, 2019
Time: 2:00 - 3:30 PM ET

 

Description
As an integral component of parenteral nutrition (PN), lipid injectable emulsions (ILEs) are not only a dense source of calories but are also a source of essential fatty acids (EFAs), important for cell membrane development and precursors to key modulators involved in cellular pathways of the immune response. As new products are developed and approved for use, it is imperative for clinicians to understand the indications for each type of ILE and potential outcomes in a variety of patient populations. 

Join ASPEN for this one of a kind webinar that will begin with a focus on the importance of ILEs in health and disease and the Food and Drug Administration (FDA) indications for all currently available formulations. After you have built your foundation of knowledge on ILEs, you will have the opportunity to hear from your colleagues who will discuss their experiences using ILEs in a variety of patient populations. You will not want to miss this opportunity to enhance your knowledge on ILEs to better care for your patients. 
 

Learning Objectives

  1. List the injectable lipid emulsion products available in the United States and the US Food and Drug Administration (FDA) approved indications for use
  2. Identify patients who may potentially benefit from PN with an ILE formulation that contains fish oil (ω-3).
  3. Describe the potential impact that conversion to four-oil lipid emulsion can have on long term HPN patients who are exhibiting early signs of parenteral nutrition-associated liver disease (PNALD).
  4. Evaluate changes observed in home PN population of patients transitioned to four-oil ILE over a twelve-month period.
  5. Review safety and efficacy of four-oil ILE over various treatment durations and examine adverse events and their likelihood of correlation to four-oil ILE.
  6. Describe how transitioning from SO ILE to four-oil ILE can impact bilirubin levels and EFA profile in pediatric intestinal failure patients
     

Faculty and Topics
Introduction of ILE and Importance in Health and Disease
FDA Indications for Currently Available Formulations

Todd Mattox, PharmD, BCNSP, Critical Care and Nutrition Support Pharmacist, Department of Pharmacy, Moffit Cancer, Tampa, FL

 

Case Presentations
Evaluation of a New Four-Oil Lipid Injectable Emulsion in Patients Receiving Parenteral Nutrition
Abstract Authors:

  • Lisa Mostafavifar, PharmD, BCPS, BCNSP, Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH
  • David C. Evans, MD, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH
  • Jay M. Mirtallo, PharmD,  College of Pharmacy, The Ohio State University, Columbus, OH
  • Mara Lee Beebe, RD, Nutrition and Dietetics, Ohio State University Wexner Medical Center, Columbus, OH
  • Sheela Thomas, RD, Nutrition and Dietetics, Ohio State University Wexner Medical Center, Columbus, OH
  • Kelsey Case, PharmD student, College of Pharmacy, The Ohio State University, Columbus, OH

Presenter:
Lisa Mostafavifar, PharmD, BCPS, BCNSP,  Specialty Practice Pharmacist Acute Care Surgery & Trauma/Nutrition Support, Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH

 

Improved Liver Function Test Results in Long-term Home Parenteral Nutrition Patients Converted to Four Oil Lipid Emulsion
Abstract Authors:

  • Casey P. Cooper, PharmD, CNSC, Pharmacy, Amerita, Inc, Amarillo, TX
  • Deborah L. Stevenson, MS, RDN, Pharmacy, Amerita, Inc, Rochester Hills, MI

Presenter:
Casey P. Cooper, PharmD, CNSC, Pharmacy Manager, Pharmacy, Amerita, Inc, Amarillo, TX

 

Alternative Lipid Emulsion Utilization in the HPN population: Patient Characteristics and Clinical Observations
Abstract Authors:

  • Hannah Heredia, MS, RD, CNSC, Parenteral Nutrition, BriovaRx Infusion, Chandler, AZ
  • Paul Choi, PharmD, BCNSP, Parenteral Nutrition, BriovaRx Infusion, Chandler, AZ
  • Angelina Mason, RD, LDN, CNSC, Parenteral Nutrition, BriovaRx Infusion, Chandler, AZ
  • Kristin Kovanis, RD, CDE, CNSC, Parenteral Nutrition, BriovaRx Infusion, Chandler, AZ
  • Shirley Au, RD, CNSC, Parenteral Nutrition, BriovaRx Infusion, Chandler, AZ
  • Penny L. Allen, RD, LDN, CNSC,  Parenteral Nutrition, BriovaRx Infusion, Chandler, AZ

Presenter:
Hannah Heredia, MS, RD, CNSC, Nutrition Support Dietitian, Parenteral Nutrition, BriovaRx Infusion, Chandler, AZ

 

Pediatric intestinal failure patients transitioning to a mixed lipid emulsion: a series of cases
Abstract Authors:

  • Mary Beth Harris, MPH, RDN, CNSC, Patient Food and Nutrition Services, Michigan Medicine, C.S. Mott Children's Hospital, Ann Arbor, MI
  • Meghan A. Arnold, MD, FACS, Pediatric Surgery, Michigan Medicine, C.S. Mott Children's Hospital, Ann Arbor, MI
  • Maria L. Partipilo, PharmD, BCNSP, Michigan Medicine, Ann Arbor, MI
  • Dana B. Steien, MD, Pediatric Gastroenterology, Michigan Medicine, C.S. Mott Children's Hospital, Ann Arbor, MI
  • Lola Rosewig, MPH, RDN, CNSC, Patient Food and Nutrition Services, Michigan Medicine, C.S. Mott Children's Hospital, Ann Arbor, MI

Presenter:
Mary Beth Harris, MPH, RDN, CNSC, Patient Food and Nutrition Services, Michigan Medicine, C.S. Mott Children's Hospital, Ann Arbor, MI 

 

Total Parenteral Nutrition Using Fish Oil-containing Combination Intravenous Lipid Emulsion in a Patient with High Inflammatory Burden
Abstract Authors:

  • Joseph E. Cruz, PharmD, BCPS, Pharmacy, Englewood Hospital and Medical Center, Englewood, NJ
  • GaEun Joung, PharmD, BCPS, Pharmacy, Englewood Hospital and Medical Center, Englewood, NJ
  • Emily Kim, MS, RD, CNSC, Food and Nutrition, Englewood Hospital and Medical Center, Englewood, NJ

Presenter:
Joseph E. Cruz, PharmD, BCPS, Pharmacy, Overlook Medical Center, Summit, NJ

 

Moderator
Diego Arenas Moya, MD, Director, Clinical Nutrition and Functional Medicine, SANVITE, Zapopan, Jalisco, Mexico 

 

CE Hours: 1.5
Level: Intermediate
UAN: JA0002345-0000-19-053-L04-P

 

Interested in additional resources for staff and students? Check out these publications from the ASPEN online store:​


Event Type:Webinar
Category:Webinar
Early registration ends on Jan 31, 2019.
Regular registration starts on Feb 01, 2019 and ends on Feb 03, 2019.
Late registration starts on Feb 04, 2019.
(GMT-05:00) Eastern Time (US & Canada)

 

Registration Fees
Fee TypeEarlyRegularLate
 Chapter Registration
Member Fee: $99.00$199.00$199.00
Non-Member Fee: $99.00$199.00$199.00
 Individual Registration
Member Fee: $19.00$29.00$29.00
Non-Member Fee: $39.00$49.00$49.00
 Site Registration
Member Fee: $149.00$249.00$249.00
Non-Member Fee: $149.00$249.00$249.00